Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Gilead Sciences Inc GILD

Sector: Healthcare | Sub-Sector: Biotechnology

Gilead Sciences Inc is a research-based biopharmaceutical company that discovers, develops and commercializes new medicines for different medical sectors.
Price: $101.075 Volume: 10.9m
Change: +$1.215 % Change: +1.22%
Day High/Low: 101.819/98.59 52 Week High/Low: 116.83/63.50
Last Traded: March 26, 2015 12:15 Transaction Volume: 50
Open: 99.13 Previous Close: 99.86
Bid: 101.07 Ask: 101.23
Bid Size: 300 Ask Size: 200
Market Cap: 150.5b Shares Out: 1.5b
PE Ratio: 13.8 Dividend Yield: N/A

Latest Bullboard Posts

  • Hopefully

    0 stars

    GILD will get back to $107 in the short term as it was before the negative rating a little while ago.  Once the hurdle is breached, I...

    2 stars

  • RE:Herd mentality is well and thriving

    0 stars

    The stock continues to recover from the panic selling a few weeks ago.  The herd always unwittingly helps rumors to realize or amplify a...

    2 stars

  • Herd mentality is well and thriving

    1 star

    A couple of weeks ago, a U.S. investment bank warned that GILD could drop to $97 (due to rival competition), the stock dropped from...

    2 stars

  • Seeking Alpha

    0 stars

    The Idiocy Of Gilead's Undervaluation Feb. 5, 2015 11:17 AM ET Gilead stock has been undervalued for most of 2014 for reasons that are...

    3 stars

  • Both

    0 stars

    GILD and ABBV are great companies.  No doubt that their share prices will go up a lot more in the near term.  Some people are worried...

    2 stars